经核查独立董事黄和发先生、仇连明先生、孙志刚先生的任职经历以及签署 的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，其配偶、 父母、子女、主要社会关系也未在公司任职，也未在公司主要股东公司担任任何 职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。因此，公司独立董事符合 上市公司独立董事管理办法》 深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对独立 董事独立性的相关要求。 江苏新瀚新材料股份有限公司董事会 2025 年 4 月 25 日 江苏新瀚新材料股份有限公司 董事会关于 2024 年度独立董事独立性自查情况的专项意见 根据《 中华人民共和国公司法》 上市公司独立董事管理办法》 深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规和 规范性文件及《 江苏新瀚新材料股份有限公司章程》的相关规定，江苏新瀚新材 料股份有限公司《 以下简称《 公司"）就 2024 年度在任独立董事黄和发先生、仇 连明先生、孙志刚先生提交的《 2024 年度独立董事独立性自查情况报告》进行评 估并出具如下专项意见： ...

前十大流通股东累计持有： 1998.44万股，累计占流通股比： 28.83%，较上期变化： -4.45万股。 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 张萍 | 699.15 | 10.08 | 不变 | | 郝国梅 | 410.18 | 5.92 | 不变 | | 叶晓明 | 300.00 | 4.33 | -30.00 | | 汤浩 | 154.21 | 2.22 | 不变 | | 滕林栋 | 96.40 | 1.39 | 7.75 | | 张泽宇 | 83.25 | 1.20 | 不变 | | 周启宝 | 81.77 | 1.18 | 3.76 | | 李康 | 74.05 | 1.07 | 新进 | | 北京银杏盛鸿投资管理有限公司-盛鸿长青私募证券 投资基金 | 56.07 | 0.81 | 新进 | | 青骊投资管理(上海)有限公司-青骊汇川3号私募证券 | | | | | 投资基金 | 43.36 | 0.63 | 新进 | | 较上个报告期退出前十大股东有 | | | | | ...

Financial Performance - The company's revenue for Q1 2025 reached ¥115,730,444.24, representing a 12.43% increase compared to ¥102,937,425.64 in the same period last year[4] - Net profit attributable to shareholders was ¥16,188,059.34, a significant increase of 47.85% from ¥10,948,940.01 year-on-year[4] - Basic earnings per share rose to ¥0.12, reflecting a 50.00% increase from ¥0.08 in the same quarter last year[4] - Net profit for the current period was ¥16,188,059.34, representing a 47.5% increase from ¥10,948,940.01 in the previous period[17] - Operating profit rose to ¥18,336,121.49, a 50.0% increase compared to ¥12,216,487.97 in the previous period[17] Cash Flow - The net cash flow from operating activities improved to ¥2,675,719.68, a remarkable increase of 242.86% compared to a negative cash flow of -¥1,873,019.37 in the previous year[4] - Cash flow from operating activities generated a net amount of ¥2,675,719.68, recovering from a negative cash flow of ¥1,873,019.37 in the previous period[19] - The company reported a net cash flow from investment activities of ¥6,779,993.96, compared to a negative cash flow of ¥29,007,990.86 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,265,510,987.30, up 0.93% from ¥1,253,854,801.37 at the end of the previous year[4] - The total liabilities decreased to ¥100,427,113.32 from ¥106,341,078.65, reflecting a reduction of about 5.5%[14] - The company's retained earnings increased to ¥397,775,880.18 from ¥381,587,820.84, showing a growth of approximately 4.2%[15] - The total equity attributable to the owners of the parent company rose to ¥1,165,083,873.98 from ¥1,147,513,722.72, which is an increase of about 1.5%[15] Investments and Income - The company reported a significant increase in investment income to ¥4,855,259.71, up 539.55% from ¥759,168.76 in the previous year[7] - Cash inflow from investment activities totaled ¥549,862,339.36, significantly higher than ¥112,061,267.48 in the previous period[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,099, with the largest shareholder holding 25.55% of the shares[9] - The total number of common shareholders at the end of the reporting period is 16,099[10] - The number of shareholders holding more than 5% of shares includes 郝国梅 with 3.05% and 4,101,809 shares[10] - The company has no preferred shareholders or changes in restricted shares during the reporting period[11] Operating Costs - Total operating costs increased to ¥101,930,395.10, up 14.1% from ¥89,407,156.76 in the previous period[16] - Management expenses rose by 56.51% to ¥10,017,590.73, mainly due to increased safety and environmental costs[7] Inventory and Receivables - Accounts receivable increased by 47.78% to ¥90,772,100.80, primarily due to outstanding customer payments within the credit period[7] - Accounts receivable rose significantly to ¥90,772,100.80 from ¥61,421,802.68, marking an increase of about 47.8%[13] - The company reported a significant increase in inventory, which decreased to ¥52,311,593.02 from ¥55,114,626.83, a decline of about 5.1%[13] Audit Information - The company did not undergo an audit for the first quarter report[21]

Financial Performance - The company's operating revenue for 2024 was ¥419,462,944.08, a decrease of 3.66% compared to ¥435,406,568.95 in 2023[18]. - Net profit attributable to shareholders for 2024 was ¥55,966,075.49, down 40.04% from ¥93,341,126.16 in 2023[18]. - Basic earnings per share for 2024 decreased to ¥0.42, down 39.13% from ¥0.69 in 2023[18]. - The company reported a weighted average return on equity of 4.96% for 2024, down from 8.62% in 2023[18]. - The company's main business revenue for the chemical new materials segment was CNY 408.63 million, a decrease of 3.39% year-on-year, with a gross margin of 24.88%, down 8.38% from the previous year[83]. - The revenue from the core raw material for specialty engineering plastics decreased by 31.32% to 175.07 million yuan in 2024, compared to 254.90 million yuan in 2023[81]. - The revenue from cosmetic raw materials increased by 77.32% to 93.58 million yuan in 2024, compared to 52.78 million yuan in 2023[81]. - The company reported a total fundraising amount of 620 million yuan, with a net amount of 554.79 million yuan raised[112]. Cash Flow and Investments - The cash flow from operating activities increased significantly to ¥139,428,467.82, a 525.70% increase from ¥22,283,603.87 in 2023[18]. - The net cash flow from operating activities increased by 525.70% year-on-year, reaching ¥139,428,467.82, primarily due to increased sales efforts and reduced inventory levels[96]. - The net cash flow from investment activities decreased by 248.53% year-on-year, resulting in a net outflow of ¥274,445,729.09, mainly due to increased idle funds in financial management[96]. - The total cash and cash equivalents decreased by 204.25% year-on-year, amounting to a net decrease of ¥152,529,899.06, primarily due to increased idle funds and trading financial assets[96]. - The company's total investment amount for the reporting period was ¥1,509,599,407.13, representing a 31.33% increase compared to ¥1,149,485,223.32 in the previous year[105]. Shareholder and Governance Matters - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares, totaling 13,452,400 RMB, which represents 100% of the profit distribution[191][192]. - The company will also increase its capital by issuing 3 additional shares for every 10 shares held, based on a total share capital of 134,524,000 shares[192]. - The company held three shareholder meetings during the reporting period, ensuring compliance with legal procedures and enhancing shareholder participation through both in-person and online voting methods[145]. - The board of directors consists of 9 members, including 3 independent directors, and held seven meetings, adhering to relevant laws and regulations[146]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, with no instances of asset occupation or financial guarantees provided to related parties[148][151][152][153][154]. Market and Product Development - The company’s main business involves the research, production, and sales of aromatic ketone products, including specialty engineering plastics and photoinitiators[28]. - Major clients include international chemical groups such as SYENSQO, VICTREX, and EVONIK, indicating a strong market presence[29]. - The company is focusing on expanding its applications in aerospace, IT manufacturing, and biomedical sectors, leveraging the unique properties of its products[33]. - The company aims to produce 8,000 tons of aromatic ketones annually, optimizing production structure to enhance profitability and exploring new profit growth points through collaboration with downstream clients and research institutions[60]. - The company is expanding its product line in specialty engineering plastics and cosmetic raw materials, aiming for breakthroughs in product offerings[60]. Research and Development - The company has ongoing R&D projects aimed at improving product yield and purity, which are expected to create new profit growth points[93]. - The company has established a mechanism for talent development to support its expanding business needs, ensuring a skilled workforce for future growth[129]. - The company is committed to ongoing research and development in high-performance materials[163]. - The company has implemented innovative technologies that reduce emissions and enhance production safety, contributing to improved product quality and customer trust[69]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, highlighting potential operational risks[4]. - The company faces risks from intensified market competition and raw material cost fluctuations, which could lead to a decline in gross margin[136]. - To mitigate gross margin risks, the company has established long-term relationships with key suppliers to secure better pricing through fixed and large-scale procurement[136]. Employee and Management Practices - The company has a comprehensive employee welfare system, including health insurance and retirement benefits, to ensure employee satisfaction and retention[189]. - The company has established a performance-based compensation system to align employee salaries with their job performance and contributions[189]. - The company has implemented a performance-based bonus system for senior management, linking bonuses to annual operational performance[196]. - The company has a structured governance system with no differential voting rights arrangements in place[159]. Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% to $600 million[3]. - The company plans to actively explore new international markets and develop new products to reduce reliance on export revenues[139]. - The company plans to enhance its product offerings in the cosmetic raw materials sector by seeking breakthroughs in product formulations[126].

证券代码：301076 证券简称：新瀚新材 公告编号：2025-007 江苏新瀚新材料股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 江苏新瀚新材料股份有限公司（以下简称"公司"）股票（证券简称：新 瀚新材，证券代码：301076）于2025年4月22日、2025年4月23日和2025年4月24 日连续三个交易日收盘价格涨幅偏离值累计超过30%，根据《深圳证券交易所 交易规则》的有关规定，属于股票交易异常波动的情形。 二、公司关注并核实相关情况的说明 针对公司股价异常波动，公司对有关事项进行了核查，并通过现场问询方 式向公司控股股东、实际控制人就相关事项进行了核实，现就有关情况说明如 下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司关注到近期公共传媒报道了公司涉及"聚醚醚酮（PEEK）概念板块" 的相关内容。4,4'-二氟二苯酮（以下简称"DFBP"）是制备PEEK产品的关键 原料，DFBP市场增速与下游应用场景对PEEK的需求有较强的相关性，具体增速 亦受下游拓展进度影响，具 ...

并上市流通的核查意见 中泰证券股份有限公司 关于江苏新瀚新材料股份有限公司 首次公开发行前已发行股份部分解除限售 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为江苏新瀚 新材料股份有限公司（以下简称"新瀚新材"或"公司"）首次公开发行股票并在创 业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交 易所创业板股票上市规则（2024年修订）》、《深圳证券交易所上市公司自律监管 指引第2号——创业板上市公司规范运作（2023年12月修订）》等相关法律、法规 和规范性文件的规定，对新瀚新材首次公开发行前已发行股份部分解除限售并上 市流通事项进行了核查，具体核查情况如下： 一、发行股份概况 （一）首次公开发行股份情况 经中国证券监督管理委员会《关于同意江苏新瀚新材料股份有限公司首次公 开发行股票注册的批复》（证监许可［2021］2688号）同意注册，公司向社会公 众公开发行人民币普通股（A股）股票20,000,000股，并于2021年10月11日在深圳 证券交易所创业板上市。 首次公开发行股票前，公司总股本59,600,000股；公司首次公开发行股票完成 后，总股本为79,600,0 ...

并上市流通的提示性公告 证券代码：301076 证券简称：新瀚新材 公告编号：2025-006 江苏新瀚新材料股份有限公司 关于首次公开发行前已发行股份部分解除限售 本公司及董事会全体成员保证公告内容真实、准确和完整，无虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、本次上市流通的限售股为江苏新瀚新材料股份有限公司（以下简称"公 司"或"新瀚新材"）首次公开发行前已发行的部分股份； 2、本次申请解除限售股东户数共计 2 户，解除限售股份的数量为 60,569,600 股，占公司总股本的 45.0251%，限售期为自公司股票上市之日起 42 个月； 3、本次解除限售股份的上市流通日为 2025 年 4 月 11 日（星期五）。 一、发行股份概况 （一）首次公开发行股份情况 经中国证券监督管理委员会《关于同意江苏新瀚新材料股份有限公司首次公 开发行股票注册的批复》（证监许可［2021］2688 号）同意注册，公司向社会公 众公开发行人民币普通股(A 股)股票 20,000,000 股，并于 2021 年 10 月 11 日在深 圳证券交易所创业板上市。 首次公开发行股票前，公司总股本 59,600,000 股 ...

江苏新瀚新材料股份有限公司 第四届监事会第三次会议决议的公告 证券代码：301076 证券简称：新瀚新材 公告编号：2025-003 本公司及监事会全体成员保证公告内容真实、准确和完整，无虚假记载、 误导性陈述或重大遗漏。 公司监事会认为：公司开展外汇套期保值业务是为了充分运用外汇套期保值工 具有效规避和防范汇率波动带来的风险、减少汇兑损失、控制经营风险，且公司已 制定《外汇套期保值业务管理制度》，完善了相关内控制度，公司采取的针对性风 险控制措施是可行的，不存在损害公司和全体股东、尤其是中小股东利益的情形。 因此，我们同意公司在保证正常生产经营的前提下，开展额度不超过2,000万美元或 等值外币的外汇套期保值业务。 公司出具了《开展外汇套期保值业务的可行性分析报告》为上述业务的开展提 供了充分的可行性分析依据，作为议案附件同时一并由监事会审议通过。 具体内容详见公司2025年3月28日于巨潮资讯网（www.cninfo.com.cn）披露的 《关于开展外汇套期保值业务的公告》（公告编号：2025-005）。 表决结果：赞成3票，反对0票，弃权0票，审议通过。 公司监事会认为：公司预计2025年度与关联方与湖 ...

证券代码：301076 证券简称：新瀚新材 公告编号：2025-004 江苏新瀚新材料股份有限公司 关于2025年度日常关联交易预计额度的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，无虚假记载、 误导性陈述或重大遗漏。 江苏新瀚新材料股份有限公司（以下简称"公司"或"新瀚新材"）于2025年3 月28日召开了第四届董事会第三次会议和第四届监事会第三次会议，审议通过了 《关于2025年度日常关联交易预计额度的议案》，关联董事严留新先生、秦翠娥女 士、严留洪先生回避表决。同时根据《深圳证券交易所创业板股票上市规则》《公 司章程》等相关规定，本次日常关联交易预计金额不超过上市公司最近一期经审计 净资产绝对值的5%，无需提交股东大会审批。 本次关联交易不构成《上市公司重大资产重组管理办法》规定的重大资产重 组，不需要经过有关部门批准。 现将具体情况公告如下： 一、日常关联交易基本情况 （一）预计日常关联交易类别和金额 | 关联方名 关联交易 | 关联交 | 预计金额 计金额差异 | 实际发生额 | 实际发生额与预 | 披露日期及索引 | | --- | --- | --- | --- | --- | - ...

证券代码：301076 证券简称：新瀚新材 公告编号：2025-003 第四届监事会第三次会议决议的公告 本公司及监事会全体成员保证公告内容真实、准确和完整，无虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏新瀚新材料股份有限公司（以下简称"公司"）监事会于2025年3月28日 在公司会议室召开第四届监事会第三次会议。会议通知于2025年3月21日以电话 和邮件的方式送达至全体监事。本次会议应到监事3人，实到监事3人，本次会议 由监事会主席张海娟主持，本次会议的召集和召开符合《公司法》和《公司章 程》的有关规定。 二、监事会会议审议情况 经举手表决，监事会审议并通过了如下议案： 1、审议通过《关于开展外汇套期保值业务的议案》 公司监事会认为：公司开展外汇套期保值业务是为了充分运用外汇套期保值工 具有效规避和防范汇率波动带来的风险、减少汇兑损失、控制经营风险，且公司已 制定《外汇套期保值业务管理制度》，完善了相关内控制度，公司采取的针对性风 险控制措施是可行的，不存在损害公司和全体股东、尤其是中小股东利益的情形。 因此，我们同意公司在保证正常生产经营的前提下，开展额度不超过2,000万美元或 等 ...